Month: July 2019

As promised, we're releasing videos from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. To open the proceedings, our president, Keith Comito, welcomed attendees, introduced the event's speakers and sponsors, discussed the staff, goals,...

Ending Age-Related Diseases 2019 is over, and the dust is starting to settle after what can only be described as a hugely successful event for our organization. This was our second year of running a conference, and once more, we focused on the research and investment areas of rejuvenation biotechnology. Totally sold out We wish...

Researchers have shown that many interventions known to increase lifespan also share similar gene expression profiles, and this knowledge may help pave the way for identifying new interventions to increase healthy lifespan and delay the diseases of aging. Identifying longevity signatures A team of researchers, including Professor Vadim Gladyshev from Harvard Medical School, has just...

Researchers from the Beijing Institute of Brain Disorders have discovered a new method of using exosomes to deliver aptamers that prevent the accumulation of α-synuclein aggregates, which are the cause of Parkinson's disease [1]. α-Synuclein Aggregates Like Alzheimer's, Parkinson's disease is characterized by protein aggregation caused by a loss of proteostasis, one of the hallmarks...

This week on X10, Giuliano asks if it's possible to age forever without rejuvenating or dying, echoing the ancient Greek myth of Tithonus - and discussing how real-world degenerative diseases work as well.  A transcript of this episode is available below. Imagine what life would be like if you were immortal, but you kept...

Researchers have discovered a new drug that targets the mTOR pathway, which is involved in aging and metabolism. It could function as a caloric restriction mimetic, bringing about similar health benefits. The mTOR pathway The mechanistic target of rapamycin (mTOR) pathway is a part of metabolism and is one of the four major pathways that...